Login to Your Account



Crucell Shares Surge as J&J Lines Up $2.3B Bid

By Cormac Sheridan


Wednesday, September 22, 2010
Shares in Crucell NV surged more than 55 percent Friday on news that Johnson & Johnson, which already holds a 17.9 percent stake in the company, was lining up a €1.75 billion (US$2.3 billion) bid, valued at €24.75 per share, to acquire the Dutch vaccine maker outright. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription